Chemistry

Photo

Small Particles with a Big Impact

In 2022, the European Commission revised the definition of nanomaterials in a new recommendation, which supports a uniform EU regulatory framework and aims at aligning the legislation across various sectors. Therefore, particle product design is an enabling technology relevant for many sectors, such as chemicals, consumer products, foods and beverages, health, energy, and the environment.

Photo

Rewriting the Rules for Chemical Distribution

Having survived the pandemic so far in good condition, chemical distributors are well positioned to grow, provided they understand how the rules for winning have changed. Distributors that keep their customers’ needs front and center will be best positioned to succeed, regardless of what the future brings.

Photo

Proactive Supplier Risk Mitigation for Manufacturing and Testing Organizations

There is a new urgency in the market for manufacturers and testing organizations to be prepared for rapid, unexpected changes in material resource access, exacerbated by turbulent regional and global events. This focus is in addition to reinforcing routine risk mitigation activities around the raw material supply chain, adding to the relevance and impact of the topic.

Photo

Planning for the Unexpected

Dorothee Arns, Director General of FECC, discusses current challenges, market trends and her vision for the chemical distribution industry in Europe. The interview was conducted by Michael Reubold and Ralf Kempf.

Photo

Shaping the Future of the Pharma Industry

The International Society for Pharmaceutical Engineering (ISPE) announced the 2022 Facility of the Year Awards (FOYA) Category Winners – including an Honorable Mention for Iovance Biotherapeutics, to be the first company in the world to commercially produce a personalized therapy for solid tumors.

Photo

Dealing with Price Volatility

It sometimes seems that everyone running a business always thinks that times are tougher now than they used to be. For producers — and buyers — of commodity chemicals, this thinking will take the more specific form of concerns about increased price volatility.

Photo

Where Science Meets Business

From its inception in 1881, SCI's principal objective has been to further the application of chemistry and related sciences into industry for the public benefit.

Photo

The Supply Chain Dilemma

Since the middle of the 1980s, the supply chain of many chemicals has moved east. This was primarily driven by cheaper production costs in China or India, due to lower raw material prices, a cheaper asset base compared to plants in the West, and lower environmental and regulatory standards.

Photo

Expanding Into Oligonucleotides

The global market for oligonucleotide therapeutics is expanding rapidly. Bachem, an innovation-driven company based in Bubendorf, Switzerland, has entered this competitive environment a few years ago and meanwhile has passed certain milestones on its way to become a preferred oligonucleotide manufacturing partner for pharmaceutical companies.

Photo

Hexion Holding to be Sold to American Securities

The backers of Hexion Holdings have agreed to sell the company to private equity investor American Securities for $30 per share in cash. The transaction is expected to complete in the first half of 2022, following the closing of the sale of its Epoxy business to Westlake Chemical. That deal is still subject to shareholder and regulatory approval.

Photo

Bioscience Trends in China’s New Five-Year Plan

China’s 14th Five-Year Plan “145” suggests that the dynamics initiated by the previous Five-Year Plan are to be maintained and even surpassed. As in the previous planning period, high priority is given to modernizing the country and the economy through R&D.

Photo

Selecting the Right European Location for Life Sciences Activities

Agile and resilient: This is how manufacturers in the life sciences industry could be described during the Covid-19 pandemic. As disruption took hold in many other industries’ supply chains, life ­sciences companies moved to rapidly develop new products and build new capacity. They are maintaining this momentum, with pharmaceutical and biotech businesses showing continued interest in expanding existing operations in Europe or starting operations from scratch.

Photo

Fine Chemicals in China

Fu Xiangsheng, Vice Chairman of the China Petroleum and Chemical Industry Federation, characterized China`s chemical industry as having a a surplus of basic chemicals and a shortage of functional chemicals. Indeed, the share of fine chemicals as a percentage of the total industry value is only about 45% compared to 60-70% in the US and in many European countries, and 90% in Switzerland. Thus, the Chinese government is interested in supporting the development of local fine chemicals production.

Photo

Mergers & Acquisitions Are an Integral Strategic Component

In the drive to reach growth objectives, or to maintain and enhance “critical mass”, mergers & acquisitions (M&A) has been a theme for the chemical distribution industry for years. The industry leaders (by size and geographic reach) were all built through a series of such transactions. The practice is further trickling down to the smaller and mid-sized company layer of the sector, and more distributors espouse external growth options.

Photo

Small, Modular Flow Plants

In 2020, the weakness associated with global chemical supply chains was highlighted in a dramatic manner as Covid-19 was designated a global pandemic. As a result, small modular continuous flow plants are gaining attention as an appropriate solution to secure supply chains whilst ensuring safe, sustainable processes are implemented.

522 more articles

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.